Answers are grounded in this paper and cite their sources.
Background Multiple myeloma is a genetically complex malignancy influenced by environmental and inherited factors. Genome-wide association studies have identified multiple single nucleotide polymorphisms associated with multiple myeloma risk, yet data from South Asian populations remain scarce. This study evaluated the association of multiple myeloma risk single nucleotide polymorphisms in a European population and examined cumulative genetic risk using polygenic risk scores in a Pakistani cohort. Methods A total of 337 individuals were genotyped for 24 genome-wide association study-identified single nucleotide polymorphisms using a TaqMan Assay. Polygenic risk scores were calculated using both unweighted and weighted models. Participants were stratified into polygenic risk scores quintiles, and odds ratios were computed to assess risk trends. Results Significant associations were identified for rs6746082 ( DTNB ), which conferred a protective effect ( p < 0.001), and rs7187359 ( SRCAP ), associated with increased risk under both models (log additive: p = 0.024 and dominant: p = 0.009). The unweighted polygenic risk scores indicated elevated multiple myeloma risk in the 4th quintile ( p = 0.017), while the weighted polygenic risk scores showed more consistent stratification, with individuals in the highest quintile having a 2.20-fold increased risk ( p = 0.034). Conclusion This study reinforces the polygenic basis of multiple myeloma susceptibility and demonstrates that certain genome-wide association study-identified single nucleotide polymorphisms are relevant in the Pakistani population. While weighted polygenic risk scores showed modest risk stratification, their clinical utility remains exploratory.
No takes yet. Share an insight, caveat, or question.
Mehmood et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: